Search Results

You are looking at 1 - 2 of 2 items for

  • Author: I. Howes x
  • Refine by access: All content x
Clear All Modify Search
R. K. Iles
Search for other papers by R. K. Iles in
Google Scholar
PubMed
Close
,
C. L. Lee
Search for other papers by C. L. Lee in
Google Scholar
PubMed
Close
,
I. Howes
Search for other papers by I. Howes in
Google Scholar
PubMed
Close
,
S. Davies
Search for other papers by S. Davies in
Google Scholar
PubMed
Close
,
R. Edwards
Search for other papers by R. Edwards in
Google Scholar
PubMed
Close
, and
T. Chard
Search for other papers by T. Chard in
Google Scholar
PubMed
Close

ABSTRACT

Material with the immunochemical properties of the β-core of human chorionic gonadotrophin (hCG) can be found in the urine of normal postmenopausal women. However, we have been unable to detect intact hCG (using an assay which is specific for the α–β heterodimer of intact hCG) in serum of such subjects. The levels of serum LH and urinary β-core were compared in matched samples from 28 women (serum LH: median 27 U/l, range 4-70 U/l, urinary β-core: median 0·27 μg/l, range < 0·05–0·645 μg/l). Urine (4 litres) from three postmenopausal women was concentrated, dialysed and subjected to gel exclusion chromatography on Sephadex G-100. Fractions were analysed by specific assays for LH, intact hCG, total β-hCG (free β-subunit and intact hCG), free α-subunit and β-core. Material eluting at the expected position of the β-core fragment of hCG was detected in all three samples by the β-core, β-hCG and LH assays, despite the fact that the LH antibody does not recognize the authentic β-core of pregnancy. Electrophoresis and Western blotting of the concentrated urines revealed that material of the same molecular size as β-core was recognized by the antibody to LH but not by a monoclonal antibody raised to free β-hCG which also recognizes the β-core molecule of hCG. We conclude that the predominant core-like material identified in postmenopausal urine is probably derived from the β-subunit of LH.

Journal of Endocrinology (1992) 133, 459–466

Restricted access
E. C. Osborn
Search for other papers by E. C. Osborn in
Google Scholar
PubMed
Close
,
P. L. Sugden
Search for other papers by P. L. Sugden in
Google Scholar
PubMed
Close
,
J. C. Mackenzie
Search for other papers by J. C. Mackenzie in
Google Scholar
PubMed
Close
,
D. M. Aitken
Search for other papers by D. M. Aitken in
Google Scholar
PubMed
Close
,
I. D. Chapman
Search for other papers by I. D. Chapman in
Google Scholar
PubMed
Close
,
S. Howes
Search for other papers by S. Howes in
Google Scholar
PubMed
Close
,
O. F. Mason
Search for other papers by O. F. Mason in
Google Scholar
PubMed
Close
,
G. V. Rigby
Search for other papers by G. V. Rigby in
Google Scholar
PubMed
Close
, and
J. Wilson
Search for other papers by J. Wilson in
Google Scholar
PubMed
Close

ABSTRACT

Angiotensin II and I significantly raised potassium and lowered sodium and chloride ion concentrations in arterial plasma, with peak changes occurring in the first 2 min of a 6-min infusion period. The octapeptide increased the arterial K+ level in a dose-dependent manner, but the response showed tachyphylaxis when multiple infusions of 6-min duration were administered after a recovery interval of only 5 min. Raising the arterial blood pressure by 20–33 mmHg with adrenaline and noradrenaline failed to account for the increase in arterial plasma K+ concentration produced by the two peptides. These findings, in particular the rise in K+ concentration, are discussed in relation to possible mechanisms by which angiotensin II affects arteriolar tone.

J. Endocr. (1985) 104, 143–148

Restricted access